Tuhura Biosciences Inc.

11/25/2024 | Press release | Distributed by Public on 11/25/2024 07:45

TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or[...]